MAPT and Alzheimer disease: Further, O-GlcNAcylation of Tau, another hallmark protein in AD, attenuates the hyperphosphorylation of Tau, suggesting a neuroprotective role for brain O-GlcNAc and a potential avenue for AD treatment [50].